Since mTOR inhibitor induced phosphorylation of eIF4E in a Mnk-dependent manner, combination of mTOR inhibitor and Mnk inhibitor is a promising strategy to improve the efficacy of mTOR inhibitor in human cancers [8, 19]. Here, ATP7A is linked to cancer.